About us
Our performance highlights
The infographics below present some of our performance highlights for the financial year 1 August 2024 to 31 July 2025.
Our ‘Year in numbers’ summarises our performance across our technology transfer, consultancy and venture activities, and includes some cumulative data alongside a set of ‘Longer term’ highlights.
Year in numbers
1,129
total number of ideas disclosed to Cambridge Enterprise
20
new companies formed
874
121 commercial and 753 research licences signed
372
patent applications filed
£3.2m
invested in patents and proof of concept
2,771
researchers supported
528
consultancy agreements signed
375
consultancy clients supported
£4.3m
invested in 32 spinouts
196
current companies in cash and equity portfolio as at 31/7/25
£94.2m
current value of cash and equity portfolio as at 31/7/25
£402m
total amount raised by cash and equity portfolio companies*
3.07x
multiple across realised cash investments
Longer term
£>4m
Technology Investment Fund committed into >40 projects
£4.9bn
follow-on funding raised by cash and equity portfolio companies
Impact
notable spinouts: BlueGnome, Centessa Pharmaceuticals, Solexa, VocalIQ
*across all holdings in 2024/25
